Global In-vitro Fertilization Market 2018-2024

  • 10
    Enquiry Hours

In-vitro fertilization is the process of artificial fertilization used to treat infertility or genetic problems globally. It is the most efficient assisted reproductive technology (ART), helping couples or single parents around the world. However, in-vitro fertilization does not always give successful results and its success rate varies from individual to individual. It has emerged as a preferable choice for fertility treatments in the clinical industry.

The market growth is attributed to the reduced conceiving rates, mainly in women aged 40 years or above, ovulation disorder, premature ovarian failure, uterine fibroids, damaged or blocked fallopian tube, endometriosis, impaired sperm production or function and unexplained infertility. A burgeoning medical tourism in several emerging economies, such India, Brazil, and China has fortified the demand for in-vitro fertilization treatments. Fresh Non-donor is the highest revenue-generating segment, and is expected to maintain this trend with a high growth rate throughout the analysis period. Geographically, the APAC region is estimated to dominate the global In-vitro Fertilization market during the forecasted period, majorly due to high demand for in-vitro fertilization treatments, attributed to the rising infertility in women and men in several countries. Few of the prominent players in the market are Coopersurgical Inc., Cook Medical Inc., Thermo Fisher Scientific Inc., Vitrolife AB, Irvine Scientific, EMD Sereno Inc., Genea Ltd., Rocket Medical PLC, Fertility Focus Ltd., Boston IVF, and Progyny Inc.

The report provides the complete details of various market trends and adoption rate in various segments and across the regions. The major trends, drivers, restraints, and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the in-vitro fertilization market.

This report also provides the competitive landscape of the leading players in Global In-vitro Fertilization market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific info required by the users. The customization of the report is available based on countries, vendor profiles, enterprise and vertical wise.

Market Report Scope:


Cycle Type

  • Fresh Donor
  • Frozen Donor
  • Fresh Non-donor
  • Frozen Non-donor

 Procedure Type

  • Intracytoplasmic Sperm Injection (ICSI)
  • Frozen Embryo Replacement (FER)
  • Pre-Implantation Genetic Diagnosis (PGD)
  • Others


  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Industry Outlook: Market Trends and Drivers, Restraints, and Opportunities

Request for TOC at

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

infoholic Research Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.